Siddhi Bhadekar
M. Pharm QA
Siddhi Rajendra Bhadekar is an M.Pharm professional with expertise in medical and scientific writing, literature review, publication writing, and evidence synthesis, supported by four peer-reviewed publications. She brings working knowledge of ICH-GCP, MedDRA, pharmacovigilance, ADR/AE reporting, clinical data management, and regulatory documentation. With experience across pharmaceutical R&D, Quality Control, and Quality Assurance, she combines scientific research skills with strong attention to accuracy and detail. Her background in manuscript development, publication planning, and scientific communication enables her to translate complex healthcare information into clear, reliable content.
About Siddhi
Siddhi Bhadekar (M. Pharm QA) is a writer at Pharmacally, with 66 published articles, each checked against primary sources by our editorial team.
Articles by Siddhi Bhadekar
Clinical TrialsRegeneron’s Baloncibart Delivers Sustained Heart Rate Benefits in POTS
New Drug ApprovalAbbisko’s PIMJETMI Wins FDA Approval After 56% Response in TGCT
New Drug ApprovalBayer’s SUNHARBO Wins FDA Approval as First Factor XIa Inhibitor
Drugs Safety AlertNovartis’ Zolgensma Raises New Tumorigenicity Concerns After FDA Findings
New Drug ApprovalJohnson & Johnson Wins FDA Approval for Rybrevant Faspro in HNSCC
Mergers & AcquisitionsEvommune Bets on EVO570 and VAV1 Degradation with $1.1B Hinova Deal
GenericsDr. Reddy’s Wins FDA Approval for Generic Lenacapavir Across LMICs
Health TidingsHUTCHMED Wins EU and Japan Regulatory Review for ORPATHYS–TAGRISSO
New Drug ApprovalINOVIO Wins FDA Approval for VOCERYQ to Reduce RRP Surgeries
A. Musharaf Mohammad
Aabha Dey
Aarti Bhambre
Aasritha Thippavajjala